Xebio Holdings（8281）株式概要ゼビオホールディングス株式会社は子会社を通じて日本でスポーツ用品事業を展開している。 詳細8281 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金1/6リスク分析3.15%の配当は、利益やフリーキャッシュフローによって十分にカバーされていない 過去5年間で収益は年間30.2%減少しました。 すべてのリスクチェックを見る8281 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW476,896 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA476,896 investors already sharing narrativesYour Fair ValueJP¥Current PriceJP¥1.09k69.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-2b300b2016201920222025202620282031Revenue JP¥300.0bEarnings JP¥13.4bAdvancedSet Fair ValueView all narrativesXebio Holdings Co., Ltd. 競合他社Bookoff Group HoldingsSymbol: TSE:9278Market cap: JP¥49.8bAsahiSymbol: TSE:3333Market cap: JP¥34.2bIntermesticSymbol: TSE:262AMarket cap: JP¥61.6bJapan Eyewear HoldingsSymbol: TSE:5889Market cap: JP¥59.6b価格と性能株価の高値、安値、推移の概要Xebio Holdings過去の株価現在の株価JP¥1,110.0052週高値JP¥1,215.0052週安値JP¥951.00ベータ0.271ヶ月の変化0.27%3ヶ月変化15.15%1年変化-3.81%3年間の変化9.14%5年間の変化-1.94%IPOからの変化-67.77%最新ニュースDeclared Dividend • Jul 25Final dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 29th September 2026 Payment date: 11th December 2026 Dividend yield will be 3.2%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.Reported Earnings • May 20Full year 2026 earnings released: JP¥52.27 loss per share (vs JP¥22.60 profit in FY 2025)Full year 2026 results: JP¥52.27 loss per share (down from JP¥22.60 profit in FY 2025). Revenue: JP¥252.3b (flat on FY 2025). Net loss: JP¥2.16b (down 323% from profit in FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.お知らせ • May 15Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026.お知らせ • May 10Xebio Holdings Co., Ltd. to Report Fiscal Year 2026 Results on May 15, 2026Xebio Holdings Co., Ltd. announced that they will report fiscal year 2026 results on May 15, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.50 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥16.91 (vs JP¥44.88 in 3Q 2025)Third quarter 2026 results: EPS: JP¥16.91 (down from JP¥44.88 in 3Q 2025). Revenue: JP¥64.5b (up 2.2% from 3Q 2025). Net income: JP¥700.0m (down 63% from 3Q 2025). Profit margin: 1.1% (down from 3.0% in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.最新情報をもっと見るRecent updatesDeclared Dividend • Jul 25Final dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 29th September 2026 Payment date: 11th December 2026 Dividend yield will be 3.2%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.Reported Earnings • May 20Full year 2026 earnings released: JP¥52.27 loss per share (vs JP¥22.60 profit in FY 2025)Full year 2026 results: JP¥52.27 loss per share (down from JP¥22.60 profit in FY 2025). Revenue: JP¥252.3b (flat on FY 2025). Net loss: JP¥2.16b (down 323% from profit in FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.お知らせ • May 15Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026.お知らせ • May 10Xebio Holdings Co., Ltd. to Report Fiscal Year 2026 Results on May 15, 2026Xebio Holdings Co., Ltd. announced that they will report fiscal year 2026 results on May 15, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.50 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥16.91 (vs JP¥44.88 in 3Q 2025)Third quarter 2026 results: EPS: JP¥16.91 (down from JP¥44.88 in 3Q 2025). Revenue: JP¥64.5b (up 2.2% from 3Q 2025). Net income: JP¥700.0m (down 63% from 3Q 2025). Profit margin: 1.1% (down from 3.0% in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.お知らせ • Dec 27Xebio Holdings Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026Xebio Holdings Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026Declared Dividend • Dec 12First half dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 30th March 2026 Payment date: 12th June 2026 Dividend yield will be 3.4%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.New Risk • Nov 21New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.3% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 2.6% per year over the past 5 years.New Risk • Nov 18New major risk - Revenue and earnings growthEarnings have declined by 2.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.6% per year over the past 5 years. Minor Risk Paying a dividend despite being loss-making.Reported Earnings • Nov 18Second quarter 2026 earnings released: JP¥2.95 loss per share (vs JP¥17.72 loss in 2Q 2025)Second quarter 2026 results: JP¥2.95 loss per share (improved from JP¥17.72 loss in 2Q 2025). Revenue: JP¥60.0b (flat on 2Q 2025). Net loss: JP¥122.0m (loss narrowed 84% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.お知らせ • Oct 31Xebio Holdings Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025Xebio Holdings Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025Upcoming Dividend • Sep 22Upcoming dividend of JP¥17.50 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 11 December 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: JP¥6.95 (vs JP¥63.23 in 1Q 2025)First quarter 2026 results: EPS: JP¥6.95 (down from JP¥63.23 in 1Q 2025). Revenue: JP¥64.3b (down 1.3% from 1Q 2025). Net income: JP¥288.0m (down 90% from 1Q 2025). Profit margin: 0.4% (down from 4.3% in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.分析記事 • Jul 24Xebio Holdings (TSE:8281) Is Due To Pay A Dividend Of ¥17.50Xebio Holdings Co., Ltd. ( TSE:8281 ) has announced that it will pay a dividend of ¥17.50 per share on the 11th of...分析記事 • Jul 10Xebio Holdings (TSE:8281) Has Announced A Dividend Of ¥17.50Xebio Holdings Co., Ltd. ( TSE:8281 ) has announced that it will pay a dividend of ¥17.50 per share on the 11th of...Declared Dividend • Jul 09Final dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 29th September 2025 Payment date: 11th December 2025 Dividend yield will be 3.1%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is well covered by both earnings (20% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. Earnings per share has grown by 21% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 29Xebio Holdings Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025Xebio Holdings Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025分析記事 • May 21There May Be Some Bright Spots In Xebio Holdings' (TSE:8281) EarningsThe most recent earnings report from Xebio Holdings Co., Ltd. ( TSE:8281 ) was disappointing for shareholders. However...Reported Earnings • May 10Full year 2025 earnings released: EPS: JP¥22.60 (vs JP¥58.63 in FY 2024)Full year 2025 results: EPS: JP¥22.60 (down from JP¥58.63 in FY 2024). Revenue: JP¥250.6b (up 3.4% from FY 2024). Net income: JP¥971.0m (down 63% from FY 2024). Profit margin: 0.4% (down from 1.1% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.お知らせ • May 09Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2025Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2025.Buy Or Sell Opportunity • Mar 26Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to JP¥1,300. The fair value is estimated to be JP¥1,083, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has declined by 16%.Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 12 June 2025. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).お知らせ • Mar 01Xebio Holdings Co., Ltd. to Report Fiscal Year 2025 Results on May 09, 2025Xebio Holdings Co., Ltd. announced that they will report fiscal year 2025 results on May 09, 2025Reported Earnings • Feb 16Third quarter 2025 earnings released: EPS: JP¥44.88 (vs JP¥27.71 in 3Q 2024)Third quarter 2025 results: EPS: JP¥44.88 (up from JP¥27.71 in 3Q 2024). Revenue: JP¥63.1b (up 1.6% from 3Q 2024). Net income: JP¥1.91b (up 56% from 3Q 2024). Profit margin: 3.0% (up from 2.0% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.分析記事 • Jan 21Estimating The Intrinsic Value Of Xebio Holdings Co., Ltd. (TSE:8281)Key Insights Xebio Holdings' estimated fair value is JP¥1,113 based on 2 Stage Free Cash Flow to Equity Current share...お知らせ • Jan 03Xebio Holdings Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025Xebio Holdings Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025分析記事 • Nov 19Investors Can Find Comfort In Xebio Holdings' (TSE:8281) Earnings QualityXebio Holdings Co., Ltd.'s ( TSE:8281 ) earnings announcement last week didn't impress shareholders. However, our...Reported Earnings • Nov 09Second quarter 2025 earnings released: JP¥17.72 loss per share (vs JP¥0.77 profit in 2Q 2024)Second quarter 2025 results: JP¥17.72 loss per share (down from JP¥0.77 profit in 2Q 2024). Revenue: JP¥60.0b (up 3.9% from 2Q 2024). Net loss: JP¥769.0m (down JP¥803.0m from profit in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Upcoming Dividend • Sep 20Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 11 December 2024. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.4%).お知らせ • Aug 29Xebio Holdings Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024Xebio Holdings Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024Reported Earnings • Aug 14First quarter 2025 earnings released: EPS: JP¥63.23 (vs JP¥44.94 in 1Q 2024)First quarter 2025 results: EPS: JP¥63.23 (up from JP¥44.94 in 1Q 2024). Revenue: JP¥65.1b (up 4.6% from 1Q 2024). Net income: JP¥2.79b (up 40% from 1Q 2024). Profit margin: 4.3% (up from 3.2% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 3% per year.分析記事 • Aug 06Xebio Holdings (TSE:8281) Could Be At Risk Of Shrinking As A CompanyWhen it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...お知らせ • Jun 27Xebio Holdings Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024Xebio Holdings Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024分析記事 • Jun 16Investors Appear Satisfied With Xebio Holdings Co., Ltd.'s (TSE:8281) Prospects As Shares Rocket 25%Xebio Holdings Co., Ltd. ( TSE:8281 ) shareholders would be excited to see that the share price has had a great month...Valuation Update With 7 Day Price Move • May 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥1,116, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 13x in the Specialty Retail industry in Japan. Total returns to shareholders of 30% over the past three years.お知らせ • May 22Xebio Holdings Co., Ltd. (TSE:8281) announces an Equity Buyback for 3,000,000 shares, representing 6.79% for ¥4,000 million.Xebio Holdings Co., Ltd. (TSE:8281) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares, representing 6.79% of its share capital, for ¥4,000 million worth of its common stock. The company will repurchase its shares in order to implement a flexible capital policy which responds to changes in the business environment. The share repurchase program will run until May 9, 2025. As of March 31, 2024, the company had 47,911,023 shares outstanding (excluding treasury shares) and 3,700,367 shares in treasury.分析記事 • May 21Xebio Holdings' (TSE:8281) Soft Earnings Are Actually Better Than They AppearThe most recent earnings report from Xebio Holdings Co., Ltd. ( TSE:8281 ) was disappointing for shareholders. Despite...Reported Earnings • May 12Full year 2024 earnings released: EPS: JP¥58.63 (vs JP¥122 in FY 2023)Full year 2024 results: EPS: JP¥58.63 (down from JP¥122 in FY 2023). Revenue: JP¥242.4b (up 1.3% from FY 2023). Net income: JP¥2.59b (down 52% from FY 2023). Profit margin: 1.1% (down from 2.3% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • May 12Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2024Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2024.お知らせ • Mar 27Xebio Holdings Co., Ltd. to Report Fiscal Year 2024 Results on May 10, 2024Xebio Holdings Co., Ltd. announced that they will report fiscal year 2024 results on May 10, 2024Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (1.3%).Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: JP¥27.71 (vs JP¥46.91 in 3Q 2023)Third quarter 2024 results: EPS: JP¥27.71 (down from JP¥46.91 in 3Q 2023). Revenue: JP¥62.1b (flat on 3Q 2023). Net income: JP¥1.23b (down 41% from 3Q 2023). Profit margin: 2.0% (down from 3.3% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 28Xebio Holdings Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024Xebio Holdings Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: JP¥0.77 (vs JP¥0.70 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥0.77 (up from JP¥0.70 loss in 2Q 2023). Revenue: JP¥57.8b (up 2.2% from 2Q 2023). Net income: JP¥34.0m (up JP¥65.0m from 2Q 2023). Profit margin: 0.1% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Sep 21Upcoming dividend of JP¥15.00 per share at 2.9% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 12 December 2023. Payout ratio is a comfortable 32% and the cash payout ratio is 90%. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.4%).Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: JP¥44.94 (vs JP¥71.86 in 1Q 2023)First quarter 2024 results: EPS: JP¥44.94 (down from JP¥71.86 in 1Q 2023). Revenue: JP¥62.3b (up 1.3% from 1Q 2023). Net income: JP¥1.99b (down 38% from 1Q 2023). Profit margin: 3.2% (down from 5.2% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 17Full year 2023 earnings released: EPS: JP¥124 (vs JP¥86.77 in FY 2022)Full year 2023 results: EPS: JP¥124 (up from JP¥86.77 in FY 2022). Revenue: JP¥239.3b (up 7.2% from FY 2022). Net income: JP¥5.46b (up 42% from FY 2022). Profit margin: 2.3% (up from 1.7% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.お知らせ • May 14Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2023Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per share at 3.0% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 14 June 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.5%).Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: JP¥46.91 (vs JP¥67.49 in 3Q 2022)Third quarter 2023 results: EPS: JP¥46.91 (down from JP¥67.49 in 3Q 2022). Revenue: JP¥62.3b (up 4.1% from 3Q 2022). Net income: JP¥2.07b (down 31% from 3Q 2022). Profit margin: 3.3% (down from 5.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Dec 28Xebio Holdings Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023Xebio Holdings Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Full-Time Auditor Yuichi Hoshikawa was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 13Second quarter 2023 earnings released: JP¥0.70 loss per share (vs JP¥10.59 loss in 2Q 2022)Second quarter 2023 results: JP¥0.70 loss per share (improved from JP¥10.59 loss in 2Q 2022). Revenue: JP¥56.6b (up 11% from 2Q 2022). Net loss: JP¥31.0m (loss narrowed 93% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 12 December 2022. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).お知らせ • Aug 30Xebio Holdings Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022Xebio Holdings Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022Reported Earnings • Aug 15First quarter 2023 earnings released: EPS: JP¥71.86 (vs JP¥47.05 in 1Q 2022)First quarter 2023 results: EPS: JP¥71.86 (up from JP¥47.05 in 1Q 2022). Revenue: JP¥61.5b (up 9.8% from 1Q 2022). Net income: JP¥3.18b (up 53% from 1Q 2022). Profit margin: 5.2% (up from 3.7% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.お知らせ • May 29Xebio Holdings Co., Ltd. to Report Q1, 2023 Results on Aug 12, 2022Xebio Holdings Co., Ltd. announced that they will report Q1, 2023 results on Aug 12, 2022Reported Earnings • May 19Full year 2022 earnings released: EPS: JP¥86.77 (vs JP¥9.32 in FY 2021)Full year 2022 results: EPS: JP¥86.77 (up from JP¥9.32 in FY 2021). Revenue: JP¥223.3b (up 10% from FY 2021). Net income: JP¥3.84b (up JP¥3.42b from FY 2021). Profit margin: 1.7% (up from 0.2% in FY 2021). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.お知らせ • May 15Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2022Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2022.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Full-Time Auditor Yuichi Hoshikawa was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08Xebio Holdings Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022Xebio Holdings Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 15 June 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 12Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥67.49 (up from JP¥17.01 in 3Q 2021). Revenue: JP¥59.9b (up 2.0% from 3Q 2021). Net income: JP¥2.98b (up 297% from 3Q 2021). Profit margin: 5.0% (up from 1.3% in 3Q 2021). The increase in margin was primarily driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 16Second quarter 2022 earnings released: JP¥10.59 loss per share (vs JP¥13.87 profit in 2Q 2021)The company reported a soft second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2022 results: Revenue: JP¥51.2b (up 2.1% from 2Q 2021). Net loss: JP¥468.0m (down 176% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 10 December 2021. Trailing yield: 2.7%. Lower than top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.3%).Reported Earnings • May 17Full year 2021 earnings released: EPS JP¥9.32 (vs JP¥9.23 in FY 2020)The company reported a mediocre full year result with weaker revenues, although profit margins were flat and earnings improved. Full year 2021 results: Revenue: JP¥202.4b (down 10% from FY 2020). Net income: JP¥412.0m (up 1.0% from FY 2020). Profit margin: 0.2% (in line with FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 12 June 2021. Trailing yield: 3.2%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.1%).Is New 90 Day High Low • Mar 09New 90-day high: JP¥969The company is up 18% from its price of JP¥823 on 09 December 2020. The Japanese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 5.0% over the same period.お知らせ • Mar 05Xebio Holdings Co., Ltd. to Report Fiscal Year 2021 Results on May 14, 2021Xebio Holdings Co., Ltd. announced that they will report fiscal year 2021 results on May 14, 2021Reported Earnings • Feb 14Third quarter 2021 earnings released: EPS JP¥17.01 (vs JP¥4.21 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥58.7b (up 4.0% from 3Q 2020). Net income: JP¥752.0m (up 304% from 3Q 2020). Profit margin: 1.3% (up from 0.3% in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 05New 90-day high: JP¥921The company is up 29% from its price of JP¥712 on 06 November 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 7.0% over the same period.Is New 90 Day High Low • Jan 20New 90-day high: JP¥865The company is up 21% from its price of JP¥715 on 22 October 2020. The Japanese market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 10.0% over the same period.お知らせ • Sep 06Xebio Holdings Co., Ltd. to Report Q2, 2021 Results on Nov 06, 2020Xebio Holdings Co., Ltd. announced that they will report Q2, 2021 results on Nov 06, 2020お知らせ • Jun 28Xebio Holdings Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020Xebio Holdings Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020株主還元8281JP Specialty RetailJP 市場7D1.3%1.9%1.8%1Y-3.8%38.4%33.6%株主還元を見る業界別リターン: 8281過去 1 年間で38.4 % の収益を上げたJP Specialty Retail業界を下回りました。リターン対市場: 8281は、過去 1 年間で33.6 % のリターンを上げたJP市場を下回りました。価格変動Is 8281's price volatile compared to industry and market?8281 volatility8281 Average Weekly Movement2.9%Specialty Retail Industry Average Movement4.2%Market Average Movement4.4%10% most volatile stocks in JP Market9.4%10% least volatile stocks in JP Market2.2%安定した株価: 8281 、 JP市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 8281の 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19622,446Tomoyoshi Morohashiwww.xebio.co.jpゼビオホールディングス株式会社は、子会社を通じて日本でスポーツ用品事業を営んでいる。同社はスポーツ用品とアパレルの販売に従事している。スーパースポーツゼビオ」ブランドの総合メガ専門店、「ゼビオスポーツエクスプレス」ブランドの中小型スポーツ用品専門店、「ヴィクトリア」ブランドの都市型スポーツ用品専門店、「ネクサス」ブランドの小型スポーツ用品専門店、「タケダスポーツ」ブランドのスポーツ用品専門店、「ヴィクトリアゴルフ」「ゴルフパートナー」ブランドのゴルフ用品専門店、「エルブレス」ブランドのアウトドア専門店、「next」「X'tyle」ブランドのアパレル専門店を運営している。また、「X'tyleVision」ブランドでスポーツアイウェア専門店、「Xiasis」ブランドで健康食品・フィットネス・医療用品専門店、「Free Blades」ブランドでアイスホッケークラブチーム、「ゼビオアリーナ」ブランドでスポーツアリーナ、「フラット八戸」ブランドで多目的アリーナを運営している。また、マーケティング、リサーチ・コンサルティング、イベントプロモーション、不動産管理業務、研究開発業務、スポーツ関連デジタルプラットフォームの運営、Eコマース管理業務にも携わっている。さらに、販売代理店事業、人材開発事業、人材派遣事業、クレジットカード事業も行っている。ゼビオホールディングス株式会社は1962年に設立され、郡山市に本社を置く。もっと見るXebio Holdings Co., Ltd. 基礎のまとめXebio Holdings の収益と売上を時価総額と比較するとどうか。8281 基礎統計学時価総額JP¥45.93b収益（TTM）-JP¥2.16b売上高(TTM)JP¥252.33b0.2xP/Sレシオ-21.2xPER（株価収益率8281 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計8281 損益計算書（TTM）収益JP¥252.33b売上原価JP¥157.24b売上総利益JP¥95.09bその他の費用JP¥97.26b収益-JP¥2.16b直近の収益報告Mar 31, 2026次回決算日Aug 14, 2026一株当たり利益（EPS）-52.29グロス・マージン37.69%純利益率-0.86%有利子負債／自己資本比率2.4%8281 の長期的なパフォーマンスは？過去の実績と比較を見る配当金3.2%現在の配当利回り-67%配当性向8281 配当は確実ですか？8281 配当履歴とベンチマークを見る8281 、いつまでに購入すれば配当金を受け取れますか？Xebio Holdings 配当日配当落ち日Sep 29 2026配当支払日Dec 11 2026配当落ちまでの日数51 days配当支払日までの日数124 days8281 配当は確実ですか？8281 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/07 18:40終値2026/08/07 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Xebio Holdings Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関Mayumi OginoCitigroup IncYoshimasa IkazakiDaiwa Securities Co. Ltd.Koichi HariyaIchiyoshi Research Institute Inc.6 その他のアナリストを表示
Declared Dividend • Jul 25Final dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 29th September 2026 Payment date: 11th December 2026 Dividend yield will be 3.2%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.
Reported Earnings • May 20Full year 2026 earnings released: JP¥52.27 loss per share (vs JP¥22.60 profit in FY 2025)Full year 2026 results: JP¥52.27 loss per share (down from JP¥22.60 profit in FY 2025). Revenue: JP¥252.3b (flat on FY 2025). Net loss: JP¥2.16b (down 323% from profit in FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
お知らせ • May 15Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026.
お知らせ • May 10Xebio Holdings Co., Ltd. to Report Fiscal Year 2026 Results on May 15, 2026Xebio Holdings Co., Ltd. announced that they will report fiscal year 2026 results on May 15, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.50 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥16.91 (vs JP¥44.88 in 3Q 2025)Third quarter 2026 results: EPS: JP¥16.91 (down from JP¥44.88 in 3Q 2025). Revenue: JP¥64.5b (up 2.2% from 3Q 2025). Net income: JP¥700.0m (down 63% from 3Q 2025). Profit margin: 1.1% (down from 3.0% in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Declared Dividend • Jul 25Final dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 29th September 2026 Payment date: 11th December 2026 Dividend yield will be 3.2%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.
Reported Earnings • May 20Full year 2026 earnings released: JP¥52.27 loss per share (vs JP¥22.60 profit in FY 2025)Full year 2026 results: JP¥52.27 loss per share (down from JP¥22.60 profit in FY 2025). Revenue: JP¥252.3b (flat on FY 2025). Net loss: JP¥2.16b (down 323% from profit in FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
お知らせ • May 15Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026Xebio Holdings Co., Ltd., Annual General Meeting, Jun 26, 2026.
お知らせ • May 10Xebio Holdings Co., Ltd. to Report Fiscal Year 2026 Results on May 15, 2026Xebio Holdings Co., Ltd. announced that they will report fiscal year 2026 results on May 15, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.50 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥16.91 (vs JP¥44.88 in 3Q 2025)Third quarter 2026 results: EPS: JP¥16.91 (down from JP¥44.88 in 3Q 2025). Revenue: JP¥64.5b (up 2.2% from 3Q 2025). Net income: JP¥700.0m (down 63% from 3Q 2025). Profit margin: 1.1% (down from 3.0% in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
お知らせ • Dec 27Xebio Holdings Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026Xebio Holdings Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026
Declared Dividend • Dec 12First half dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 30th March 2026 Payment date: 12th June 2026 Dividend yield will be 3.4%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has remained flat since 10 years ago. However, payments have been volatile during that time.
New Risk • Nov 21New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.3% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 2.6% per year over the past 5 years.
New Risk • Nov 18New major risk - Revenue and earnings growthEarnings have declined by 2.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.6% per year over the past 5 years. Minor Risk Paying a dividend despite being loss-making.
Reported Earnings • Nov 18Second quarter 2026 earnings released: JP¥2.95 loss per share (vs JP¥17.72 loss in 2Q 2025)Second quarter 2026 results: JP¥2.95 loss per share (improved from JP¥17.72 loss in 2Q 2025). Revenue: JP¥60.0b (flat on 2Q 2025). Net loss: JP¥122.0m (loss narrowed 84% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
お知らせ • Oct 31Xebio Holdings Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025Xebio Holdings Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025
Upcoming Dividend • Sep 22Upcoming dividend of JP¥17.50 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 11 December 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).
Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: JP¥6.95 (vs JP¥63.23 in 1Q 2025)First quarter 2026 results: EPS: JP¥6.95 (down from JP¥63.23 in 1Q 2025). Revenue: JP¥64.3b (down 1.3% from 1Q 2025). Net income: JP¥288.0m (down 90% from 1Q 2025). Profit margin: 0.4% (down from 4.3% in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
分析記事 • Jul 24Xebio Holdings (TSE:8281) Is Due To Pay A Dividend Of ¥17.50Xebio Holdings Co., Ltd. ( TSE:8281 ) has announced that it will pay a dividend of ¥17.50 per share on the 11th of...
分析記事 • Jul 10Xebio Holdings (TSE:8281) Has Announced A Dividend Of ¥17.50Xebio Holdings Co., Ltd. ( TSE:8281 ) has announced that it will pay a dividend of ¥17.50 per share on the 11th of...
Declared Dividend • Jul 09Final dividend of JP¥17.50 announcedShareholders will receive a dividend of JP¥17.50. Ex-date: 29th September 2025 Payment date: 11th December 2025 Dividend yield will be 3.1%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is well covered by both earnings (20% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. Earnings per share has grown by 21% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 29Xebio Holdings Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025Xebio Holdings Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025
分析記事 • May 21There May Be Some Bright Spots In Xebio Holdings' (TSE:8281) EarningsThe most recent earnings report from Xebio Holdings Co., Ltd. ( TSE:8281 ) was disappointing for shareholders. However...
Reported Earnings • May 10Full year 2025 earnings released: EPS: JP¥22.60 (vs JP¥58.63 in FY 2024)Full year 2025 results: EPS: JP¥22.60 (down from JP¥58.63 in FY 2024). Revenue: JP¥250.6b (up 3.4% from FY 2024). Net income: JP¥971.0m (down 63% from FY 2024). Profit margin: 0.4% (down from 1.1% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
お知らせ • May 09Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2025Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2025.
Buy Or Sell Opportunity • Mar 26Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to JP¥1,300. The fair value is estimated to be JP¥1,083, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has declined by 16%.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 12 June 2025. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).
お知らせ • Mar 01Xebio Holdings Co., Ltd. to Report Fiscal Year 2025 Results on May 09, 2025Xebio Holdings Co., Ltd. announced that they will report fiscal year 2025 results on May 09, 2025
Reported Earnings • Feb 16Third quarter 2025 earnings released: EPS: JP¥44.88 (vs JP¥27.71 in 3Q 2024)Third quarter 2025 results: EPS: JP¥44.88 (up from JP¥27.71 in 3Q 2024). Revenue: JP¥63.1b (up 1.6% from 3Q 2024). Net income: JP¥1.91b (up 56% from 3Q 2024). Profit margin: 3.0% (up from 2.0% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
分析記事 • Jan 21Estimating The Intrinsic Value Of Xebio Holdings Co., Ltd. (TSE:8281)Key Insights Xebio Holdings' estimated fair value is JP¥1,113 based on 2 Stage Free Cash Flow to Equity Current share...
お知らせ • Jan 03Xebio Holdings Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025Xebio Holdings Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025
分析記事 • Nov 19Investors Can Find Comfort In Xebio Holdings' (TSE:8281) Earnings QualityXebio Holdings Co., Ltd.'s ( TSE:8281 ) earnings announcement last week didn't impress shareholders. However, our...
Reported Earnings • Nov 09Second quarter 2025 earnings released: JP¥17.72 loss per share (vs JP¥0.77 profit in 2Q 2024)Second quarter 2025 results: JP¥17.72 loss per share (down from JP¥0.77 profit in 2Q 2024). Revenue: JP¥60.0b (up 3.9% from 2Q 2024). Net loss: JP¥769.0m (down JP¥803.0m from profit in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Upcoming Dividend • Sep 20Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 11 December 2024. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.4%).
お知らせ • Aug 29Xebio Holdings Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024Xebio Holdings Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024
Reported Earnings • Aug 14First quarter 2025 earnings released: EPS: JP¥63.23 (vs JP¥44.94 in 1Q 2024)First quarter 2025 results: EPS: JP¥63.23 (up from JP¥44.94 in 1Q 2024). Revenue: JP¥65.1b (up 4.6% from 1Q 2024). Net income: JP¥2.79b (up 40% from 1Q 2024). Profit margin: 4.3% (up from 3.2% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 3% per year.
分析記事 • Aug 06Xebio Holdings (TSE:8281) Could Be At Risk Of Shrinking As A CompanyWhen it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
お知らせ • Jun 27Xebio Holdings Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024Xebio Holdings Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024
分析記事 • Jun 16Investors Appear Satisfied With Xebio Holdings Co., Ltd.'s (TSE:8281) Prospects As Shares Rocket 25%Xebio Holdings Co., Ltd. ( TSE:8281 ) shareholders would be excited to see that the share price has had a great month...
Valuation Update With 7 Day Price Move • May 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥1,116, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 13x in the Specialty Retail industry in Japan. Total returns to shareholders of 30% over the past three years.
お知らせ • May 22Xebio Holdings Co., Ltd. (TSE:8281) announces an Equity Buyback for 3,000,000 shares, representing 6.79% for ¥4,000 million.Xebio Holdings Co., Ltd. (TSE:8281) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares, representing 6.79% of its share capital, for ¥4,000 million worth of its common stock. The company will repurchase its shares in order to implement a flexible capital policy which responds to changes in the business environment. The share repurchase program will run until May 9, 2025. As of March 31, 2024, the company had 47,911,023 shares outstanding (excluding treasury shares) and 3,700,367 shares in treasury.
分析記事 • May 21Xebio Holdings' (TSE:8281) Soft Earnings Are Actually Better Than They AppearThe most recent earnings report from Xebio Holdings Co., Ltd. ( TSE:8281 ) was disappointing for shareholders. Despite...
Reported Earnings • May 12Full year 2024 earnings released: EPS: JP¥58.63 (vs JP¥122 in FY 2023)Full year 2024 results: EPS: JP¥58.63 (down from JP¥122 in FY 2023). Revenue: JP¥242.4b (up 1.3% from FY 2023). Net income: JP¥2.59b (down 52% from FY 2023). Profit margin: 1.1% (down from 2.3% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • May 12Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2024Xebio Holdings Co., Ltd., Annual General Meeting, Jun 27, 2024.
お知らせ • Mar 27Xebio Holdings Co., Ltd. to Report Fiscal Year 2024 Results on May 10, 2024Xebio Holdings Co., Ltd. announced that they will report fiscal year 2024 results on May 10, 2024
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 39% but the company is not cash flow positive. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (1.3%).
Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: JP¥27.71 (vs JP¥46.91 in 3Q 2023)Third quarter 2024 results: EPS: JP¥27.71 (down from JP¥46.91 in 3Q 2023). Revenue: JP¥62.1b (flat on 3Q 2023). Net income: JP¥1.23b (down 41% from 3Q 2023). Profit margin: 2.0% (down from 3.3% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 28Xebio Holdings Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024Xebio Holdings Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024
Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: JP¥0.77 (vs JP¥0.70 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥0.77 (up from JP¥0.70 loss in 2Q 2023). Revenue: JP¥57.8b (up 2.2% from 2Q 2023). Net income: JP¥34.0m (up JP¥65.0m from 2Q 2023). Profit margin: 0.1% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥15.00 per share at 2.9% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 12 December 2023. Payout ratio is a comfortable 32% and the cash payout ratio is 90%. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.4%).
Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: JP¥44.94 (vs JP¥71.86 in 1Q 2023)First quarter 2024 results: EPS: JP¥44.94 (down from JP¥71.86 in 1Q 2023). Revenue: JP¥62.3b (up 1.3% from 1Q 2023). Net income: JP¥1.99b (down 38% from 1Q 2023). Profit margin: 3.2% (down from 5.2% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 17Full year 2023 earnings released: EPS: JP¥124 (vs JP¥86.77 in FY 2022)Full year 2023 results: EPS: JP¥124 (up from JP¥86.77 in FY 2022). Revenue: JP¥239.3b (up 7.2% from FY 2022). Net income: JP¥5.46b (up 42% from FY 2022). Profit margin: 2.3% (up from 1.7% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
お知らせ • May 14Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2023Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per share at 3.0% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 14 June 2023. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.5%).
Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: JP¥46.91 (vs JP¥67.49 in 3Q 2022)Third quarter 2023 results: EPS: JP¥46.91 (down from JP¥67.49 in 3Q 2022). Revenue: JP¥62.3b (up 4.1% from 3Q 2022). Net income: JP¥2.07b (down 31% from 3Q 2022). Profit margin: 3.3% (down from 5.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Dec 28Xebio Holdings Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023Xebio Holdings Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Full-Time Auditor Yuichi Hoshikawa was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 13Second quarter 2023 earnings released: JP¥0.70 loss per share (vs JP¥10.59 loss in 2Q 2022)Second quarter 2023 results: JP¥0.70 loss per share (improved from JP¥10.59 loss in 2Q 2022). Revenue: JP¥56.6b (up 11% from 2Q 2022). Net loss: JP¥31.0m (loss narrowed 93% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 12 December 2022. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).
お知らせ • Aug 30Xebio Holdings Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022Xebio Holdings Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022
Reported Earnings • Aug 15First quarter 2023 earnings released: EPS: JP¥71.86 (vs JP¥47.05 in 1Q 2022)First quarter 2023 results: EPS: JP¥71.86 (up from JP¥47.05 in 1Q 2022). Revenue: JP¥61.5b (up 9.8% from 1Q 2022). Net income: JP¥3.18b (up 53% from 1Q 2022). Profit margin: 5.2% (up from 3.7% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
お知らせ • May 29Xebio Holdings Co., Ltd. to Report Q1, 2023 Results on Aug 12, 2022Xebio Holdings Co., Ltd. announced that they will report Q1, 2023 results on Aug 12, 2022
Reported Earnings • May 19Full year 2022 earnings released: EPS: JP¥86.77 (vs JP¥9.32 in FY 2021)Full year 2022 results: EPS: JP¥86.77 (up from JP¥9.32 in FY 2021). Revenue: JP¥223.3b (up 10% from FY 2021). Net income: JP¥3.84b (up JP¥3.42b from FY 2021). Profit margin: 1.7% (up from 0.2% in FY 2021). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
お知らせ • May 15Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2022Xebio Holdings Co., Ltd., Annual General Meeting, Jun 29, 2022.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Full-Time Auditor Yuichi Hoshikawa was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08Xebio Holdings Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022Xebio Holdings Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 15 June 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 12Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥67.49 (up from JP¥17.01 in 3Q 2021). Revenue: JP¥59.9b (up 2.0% from 3Q 2021). Net income: JP¥2.98b (up 297% from 3Q 2021). Profit margin: 5.0% (up from 1.3% in 3Q 2021). The increase in margin was primarily driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 16Second quarter 2022 earnings released: JP¥10.59 loss per share (vs JP¥13.87 profit in 2Q 2021)The company reported a soft second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2022 results: Revenue: JP¥51.2b (up 2.1% from 2Q 2021). Net loss: JP¥468.0m (down 176% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 10 December 2021. Trailing yield: 2.7%. Lower than top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.3%).
Reported Earnings • May 17Full year 2021 earnings released: EPS JP¥9.32 (vs JP¥9.23 in FY 2020)The company reported a mediocre full year result with weaker revenues, although profit margins were flat and earnings improved. Full year 2021 results: Revenue: JP¥202.4b (down 10% from FY 2020). Net income: JP¥412.0m (up 1.0% from FY 2020). Profit margin: 0.2% (in line with FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 12 June 2021. Trailing yield: 3.2%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.1%).
Is New 90 Day High Low • Mar 09New 90-day high: JP¥969The company is up 18% from its price of JP¥823 on 09 December 2020. The Japanese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 5.0% over the same period.
お知らせ • Mar 05Xebio Holdings Co., Ltd. to Report Fiscal Year 2021 Results on May 14, 2021Xebio Holdings Co., Ltd. announced that they will report fiscal year 2021 results on May 14, 2021
Reported Earnings • Feb 14Third quarter 2021 earnings released: EPS JP¥17.01 (vs JP¥4.21 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥58.7b (up 4.0% from 3Q 2020). Net income: JP¥752.0m (up 304% from 3Q 2020). Profit margin: 1.3% (up from 0.3% in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 05New 90-day high: JP¥921The company is up 29% from its price of JP¥712 on 06 November 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 7.0% over the same period.
Is New 90 Day High Low • Jan 20New 90-day high: JP¥865The company is up 21% from its price of JP¥715 on 22 October 2020. The Japanese market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 10.0% over the same period.
お知らせ • Sep 06Xebio Holdings Co., Ltd. to Report Q2, 2021 Results on Nov 06, 2020Xebio Holdings Co., Ltd. announced that they will report Q2, 2021 results on Nov 06, 2020
お知らせ • Jun 28Xebio Holdings Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020Xebio Holdings Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020
